Seikagaku Grows in FY19 on Strength in U.S. Market

Gel-One Viscosupplement

Seikagaku reported FY 4Q19 orthopedic revenue of ¥2,555.5 million (USD $23.1 million), -22.4% vs. 4Q18, with full-year FY19 revenue of USD $130.4 million, +4.7%. The company’s sales of ARTZ in Japan were down due to the overall contraction of the domestic market as well as continuing price pressure from NHI drug price reductions. Seikagaku...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us